I also highlighted this:
Paradigm is scheduled to complete enrolment of stage 1 of the PARA_OA_002 clinical trial by the end of the current quarter.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $206.0K | 1.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 217901 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 57971 | 5 |
View Market Depth
| Last trade - 15.09pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |